Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Muscarinic acetylcholine receptor subtype 4 antagonists in the treatment of anemia

Muscarinic acetylcholine receptor subtype 4 antagonists in the treatment of anemia

US Patent 12497411 · Granted Dec 16, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds for use in synthesis of peptidomimetics2025
HMGB1 antagonist treatment of severe sepsis2024
HMGB1 antagonist treatment of acute lung injury2023
Treatment of HMGB1-mediated inflammation2023
HMGB1 antagonist treatment of severe sepsis2022
HMGB1 antagonist2022
HMGB1 antagonist treatment of diabetic peripheral neuropathy2022
Thiosemicarbazates and uses thereof2022
Compounds for use in synthesis of peptidomimetics2022
Compounds for use in synthesis of peptidomimetics2021
Treatment of HMGB1-mediated inflammation2020
Treatment of solid tumors by inhibiting MRK/ZAK2018